Oct 12, 2026 08:00AM
Sep 10, 2026 04:57AM
Sep 4, 2026 06:00AM
Sep 1, 2026 07:30AM
Aug 4, 2026 06:57AM
Aug 3, 2026 04:41PM
Jul 13, 2026 07:30AM Stoke Therapeutics names Thomas McCauley as chief scientific officer
Jul 13, 2026 05:10AM
May 7, 2026 04:15PM
Mar 20, 2026 06:58AM
Mar 18, 2026 04:09PM
Feb 5, 2026 03:30AM
Jan 12, 2026 07:45AM
Jan 12, 2026 06:44AM Stoke Therapeutics (STOK) PT Raised to $36 at Wedbush
Jan 5, 2026 07:54AM
Jan 5, 2026 04:34AM
Jan 5, 2026 04:24AM
Dec 16, 2025 06:53AM
Dec 5, 2025 09:01AM
Dec 1, 2025 07:31AM
Nov 17, 2025 07:30AM Stoke and Biogen publish data showing Dravet syndrome severity
Nov 4, 2025 05:57PM
Oct 13, 2025 01:34PM
Oct 10, 2025 07:23AM
Oct 9, 2025 04:31PM
Sep 2, 2025 07:03AM
Sep 2, 2025 07:01AM
Aug 25, 2025 07:00AM Stoke Therapeutics and Biogen to present zorevunersen data at epilepsy congress
Aug 18, 2025 05:11AM
Aug 12, 2025 04:04PM
Jul 18, 2025 02:02AM
Jul 14, 2025 06:57AM
Jul 9, 2025 04:04PM
May 15, 2025 06:48AM
May 14, 2025 01:54AM Stoke Therapeutics, Inc. (STOK) Tops Q1 EPS by 182c
Mar 20, 2025 06:43AM
Mar 18, 2025 07:01AM
Mar 18, 2025 06:58AM
Feb 18, 2025 09:58AM
Feb 18, 2025 08:03AM
Jan 8, 2025 06:36AM
Jan 7, 2025 07:02AM Stoke Therapeutics Inc. (STOK) Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen
Dec 5, 2024 07:00AM
Dec 4, 2024 07:01AM
Nov 5, 2024 07:43AM
Oct 9, 2024 04:20PM
Sep 11, 2024 09:10AM
Sep 11, 2024 06:38AM
Sep 10, 2024 07:02AM Stoke Therapeutics (STOK) Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition
Sep 4, 2024 08:04AM

466,309 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All